Newsfeeds Archive - Page 7 of 9

9 minute read

Earnings

Earnings Scheduled For February 16, 2023

February 16, 6:07 AM

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year 2022.

AEL

1 minute read

‘It’s The Only China Stock I’d Buy’: Cramer On This E-Commerce Stock

By Lisa Levin

January 26, 9:19 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Alibaba Group Holding Limited (NYSE: BABA) is the only China stock he would buy.

BABA

5 minute read

‘FTX Users May Seek DeFi Alternatives,’ Interview With Origin Protocol’s Andra Nicolau

By Ryan McNamara

November 28, 11:04 AM

In a risk-off environment where cryptocurrency has plummeted to a fraction of its previous valuation, it’s no secret raising capital in 2022 has become a challenge for startups and industry behemoths alike.

OGN

5 minute read

‘FTX Users May Seek DeFi Alternatives,’ Interview With Origin Protocol’s Andra Nicolau

By Ryan McNamara

November 28, 11:04 AM

OGN

5 minute read

‘FTX Users May Seek DeFi Alternatives,’ Interview With Origin Protocol’s Andra Nicolau

By Ryan McNamara

November 28, 11:03 AM

OGN

31 minute read

Earnings

Earnings Scheduled For November 3, 2022

By Benzinga Insights

November 3, 5:42 AM

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

AAOI

1 minute read

This Organon Analyst Is Bearish On Heels Of Health Care Company’s Merck Spinoff

By Priya Nigam

October 14, 11:42 AM

Although management has largely delivered on the post-spin objectives, Organon & Co. (NYSE: OGN) has no pipeline assets and its financial leverage limits potential M&A to invest in future growth drivers, according to Bank of America (BofA) Securities.

OGN

2 minute read

Analyst Ratings

What 4 Analyst Ratings Have To Say About Organon

By Benzinga Insights

October 14, 11:28 AM

Over the past 3 months, 4 analysts have published their opinion on Organon (NYSE:OGN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

OGN